OSMOTICA PHARMACEUTICALS PLC (OSMT) Stock Price, Quote, News and Overview
NASDAQ:OSMT - Nasdaq - Common Stock
OSMT Quote, Performance and Key Statistics
1.11
-0.02 (-1.77%)
The current stock price of OSMT is 1.11 null. In the past month the price increased by 12.8%. In the past year, price decreased by -75.11%.
OSMT Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 55.04 | 718.00B | ||
| JNJ | JOHNSON & JOHNSON | 15.06 | 364.11B | ||
| NVO | NOVO-NORDISK A/S-SPONS ADR | 18.6 | 285.74B | ||
| NVS | NOVARTIS AG-SPONSORED ADR | 13.19 | 216.45B | ||
| AZN | ASTRAZENECA PLC-SPONS ADR | 18.5 | 213.34B | ||
| MRK | MERCK & CO. INC. | 9.76 | 191.40B | ||
| PFE | PFIZER INC | 7.11 | 129.48B | ||
| SNY | SANOFI-ADR | 13.64 | 126.52B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 6.37 | 95.14B | ||
| GSK | GSK PLC-SPON ADR | 6.91 | 76.16B | ||
| ZTS | ZOETIS INC | 27.08 | 72.73B | ||
| HLN | HALEON PLC-ADR | 22.5 | 48.70B |
Related stock screener links
About OSMT
Company Profile
Osmotica Pharmaceuticals Plc engages in the development and commercialization of products for neurology and women's health. The company is headquartered in Bridgewater, New Jersey and currently employs 302 full-time employees. The company went IPO on 2018-10-12. The firm is focused on the developing and commercialization of specialty products that target markets with underserved patient populations. The firm sells portfolio products consisting of promoted products and non-promoted products, which incorporate its Osmodex drug delivery system. The Company’s Osmodex drug delivery system uses osmotic pressure to provide a controlled drug release and is adaptable to many different combinations of immediate-release, extended-release and controlled- or delayed-release formulations that contain one or more drugs. The Company’s non-promoted product portfolio includes methylphenidate ER and venlafaxine extended-release tablets (VERT) as well as ANDAs and prescription dietary supplements. Its promoted products are led by Divigel and M-72 (methylphenidate hydrochloride extended-release tablets, 72 mg).
Company Info
OSMOTICA PHARMACEUTICALS PLC
400 Crossing Blvd
Bridgewater NEW JERSEY 08807 US
CEO: Brian Markison
Employees: 302
Phone: 19088091300.0
OSMOTICA PHARMACEUTICALS PLC / OSMT FAQ
What is the stock price of OSMOTICA PHARMACEUTICALS PLC today?
The current stock price of OSMT is 1.11 null. The price decreased by -1.77% in the last trading session.
What is the ticker symbol for OSMOTICA PHARMACEUTICALS PLC stock?
The exchange symbol of OSMOTICA PHARMACEUTICALS PLC is OSMT and it is listed on the Nasdaq exchange.
On which exchange is OSMT stock listed?
OSMT stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for OSMOTICA PHARMACEUTICALS PLC stock?
10 analysts have analysed OSMT and the average price target is 5.87 null. This implies a price increase of 428.38% is expected in the next year compared to the current price of 1.11. Check the OSMOTICA PHARMACEUTICALS PLC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is OSMOTICA PHARMACEUTICALS PLC worth?
OSMOTICA PHARMACEUTICALS PLC (OSMT) has a market capitalization of 70.07M null. This makes OSMT a Micro Cap stock.
How many employees does OSMOTICA PHARMACEUTICALS PLC have?
OSMOTICA PHARMACEUTICALS PLC (OSMT) currently has 302 employees.
What are the support and resistance levels for OSMOTICA PHARMACEUTICALS PLC (OSMT) stock?
OSMOTICA PHARMACEUTICALS PLC (OSMT) has a support level at 1.05 and a resistance level at 1.18. Check the full technical report for a detailed analysis of OSMT support and resistance levels.
Is OSMOTICA PHARMACEUTICALS PLC (OSMT) expected to grow?
The Revenue of OSMOTICA PHARMACEUTICALS PLC (OSMT) is expected to decline by -89.33% in the next year. Check the estimates tab for more information on the OSMT EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy OSMOTICA PHARMACEUTICALS PLC (OSMT) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of OSMT, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of OSMT, evaluating the profitability, health, valuation and growth aspects
- OSMOTICA PHARMACEUTICALS PLC (OSMT) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- OSMOTICA PHARMACEUTICALS PLC (OSMT) Sales and EPS estimates to see what analysts future expectations are.
- OSMOTICA PHARMACEUTICALS PLC (OSMT) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- OSMOTICA PHARMACEUTICALS PLC (OSMT) Insider and Institutional Ownership to learn about the owners and their transactions.
- OSMOTICA PHARMACEUTICALS PLC (OSMT) Stock Chart to make your own analysis
- OSMOTICA PHARMACEUTICALS PLC (OSMT) Latest news and press-releases to stay up to date.
Does OSMOTICA PHARMACEUTICALS PLC (OSMT) stock pay dividends?
OSMT does not pay a dividend.
What is the Price/Earnings (PE) ratio of OSMOTICA PHARMACEUTICALS PLC (OSMT)?
OSMOTICA PHARMACEUTICALS PLC (OSMT) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.59).
OSMT Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to OSMT. When comparing the yearly performance of all stocks, OSMT is a bad performer in the overall market: 92.8% of all stocks are doing better.
OSMT Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to OSMT. Both the profitability and financial health of OSMT have multiple concerns.
OSMT Financial Highlights
Over the last trailing twelve months OSMT reported a non-GAAP Earnings per Share(EPS) of -1.59. The EPS decreased by -72.83% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | -150.14% | ||
| ROA | -100.12% | ||
| ROE | N/A | ||
| Debt/Equity | 0 |
OSMT Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 84% to OSMT. The Buy consensus is the average rating of analysts ratings from 10 analysts.
For the next year, analysts expect an EPS growth of 18.29% and a revenue growth -89.33% for OSMT